Agalsidase beta treatment of patientswith Fabry disease for 54 months reduces globotriaosylceramide accumulation in multiple cell types of the kidney

✍ Scribed by S. Waldek

• Book ID: 117321758
• Publisher: Elsevier Science
• Year: 2007
• Tongue: English
• Weight: 331 KB
• Volume: 29
• Category: Article
• ISSN: 0149-2918
• DOI: 10.1016/s0149-2918(07)80150-0